Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dextroketamine versus dexmedetomidine in elective laparoscopic cholecystectomy
RBR-9hhp2y8Phase 3Recruiting
- Sponsor
- Hospital Universitário Gaffrée e Guinle
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexmedetomidine in cholecystitis (3 arms), sponsored by Hospital Universitário Gaffrée e Guinle. Primary endpoint: Hemodynamic parameter variation. Started Mar 2023; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
cholecystitis
Beyond the preview
Go deeper on RBR-9hhp2y8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-9hhp2y8.